Key facts
- Provisio Medical’s last known valuation is $81.3M (Nov 2022).
- It has raised $47.3M across 10 recorded rounds; the latest was Seed Round ($5.0M) in Jun 2024.
- Notable investors include MedTech Innovator.
- Provisio Medical has filed 15 Form Ds with the SEC since 2016, most recently May 2025 ($1.3M sold to 4 investors).
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 10 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Provisio Medical
Funding rounds
10 roundsAbout Provisio Medical
Developer of sonic lumen tomography technology designed to offer accurate and precise real-time flow lumen dimensions to clients. The company's technology can easily be integrated into many of the endovascular devices that physicians use, enabling healthcare providers to get the exact information that they need to improve vessel sizing accuracy for peripheral and coronary vascular interventions.
- Sector
- Healthcare
- HQ
- San Diego, CA, United States
- Founded
- 2014
- Employees
- 25
- Website
- provisiomedical.com/
- Ownership
- Privately Held (backing)
Provisio Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Provisio Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Provisio Medical in its N-PORT filings yet. We sweep new filings monthly.